Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK PHARMA CIPLA GSK PHARMA/
CIPLA
 
P/E (TTM) x 62.2 32.2 193.1% View Chart
P/BV x 18.9 5.2 365.4% View Chart
Dividend Yield % 1.6 0.6 289.6%  

Financials

 GSK PHARMA   CIPLA
EQUITY SHARE DATA
    GSK PHARMA
Mar-23
CIPLA
Mar-23
GSK PHARMA/
CIPLA
5-Yr Chart
Click to enlarge
High Rs1,6841,185 142.1%   
Low Rs1,231852 144.4%   
Sales per share (Unadj.) Rs191.9281.9 68.1%  
Earnings per share (Unadj.) Rs35.935.1 102.1%  
Cash flow per share (Unadj.) Rs39.849.7 80.1%  
Dividends per share (Unadj.) Rs32.008.50 376.5%  
Avg Dividend yield %2.20.8 263.2%  
Book value per share (Unadj.) Rs102.9289.2 35.6%  
Shares outstanding (eoy) m169.41807.15 21.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.63.6 210.1%   
Avg P/E ratio x40.629.0 140.1%  
P/CF ratio (eoy) x36.720.5 178.7%  
Price / Book Value ratio x14.23.5 402.2%  
Dividend payout %89.224.2 368.7%   
Avg Mkt Cap Rs m246,858822,164 30.0%   
No. of employees `000NANA-   
Total wages/salary Rs m5,95038,301 15.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m32,517227,531 14.3%  
Other income Rs m1,0075,121 19.7%   
Total revenues Rs m33,524232,653 14.4%   
Gross profit Rs m8,03348,079 16.7%  
Depreciation Rs m65811,721 5.6%   
Interest Rs m181,095 1.7%   
Profit before tax Rs m8,36440,384 20.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,28812,029 19.0%   
Profit after tax Rs m6,07628,355 21.4%  
Gross profit margin %24.721.1 116.9%  
Effective tax rate %27.429.8 91.8%   
Net profit margin %18.712.5 150.0%  
BALANCE SHEET DATA
Current assets Rs m24,943168,051 14.8%   
Current liabilities Rs m13,26450,333 26.4%   
Net working cap to sales %35.951.7 69.4%  
Current ratio x1.93.3 56.3%  
Inventory Days Days9773 132.8%  
Debtors Days Days2167 3,318.0%  
Net fixed assets Rs m6,988117,318 6.0%   
Share capital Rs m1,6941,614 104.9%   
"Free" reserves Rs m15,735231,845 6.8%   
Net worth Rs m17,430233,460 7.5%   
Long term debt Rs m00-   
Total assets Rs m31,930290,067 11.0%  
Interest coverage x462.637.9 1,221.6%   
Debt to equity ratio x00-  
Sales to assets ratio x1.00.8 129.8%   
Return on assets %19.110.2 188.0%  
Return on equity %34.912.1 287.0%  
Return on capital %48.117.8 270.7%  
Exports to sales %022.6 0.0%   
Imports to sales %48.18.9 541.4%   
Exports (fob) Rs mNA51,516 0.0%   
Imports (cif) Rs m15,63020,202 77.4%   
Fx inflow Rs m1,62264,282 2.5%   
Fx outflow Rs m15,63020,202 77.4%   
Net fx Rs m-14,00844,080 -31.8%   
CASH FLOW
From Operations Rs m4,84232,377 15.0%  
From Investments Rs m8,079-23,885 -33.8%  
From Financial Activity Rs m-15,433-9,583 161.0%  
Net Cashflow Rs m-2,512-968 259.6%  

Share Holding

Indian Promoters % 0.0 13.4 -  
Foreign collaborators % 75.0 20.0 374.3%  
Indian inst/Mut Fund % 11.6 50.0 23.2%  
FIIs % 2.9 25.7 11.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 66.5 37.6%  
Shareholders   114,663 425,731 26.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on GSK Pharma vs Cipla

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GSK Pharma vs Cipla Share Price Performance

Period GSK Pharma Cipla S&P BSE HEALTHCARE
1-Day 3.26% 1.94% 1.18%
1-Month -9.77% 1.25% -0.75%
1-Year 52.63% 68.02% 61.82%
3-Year CAGR 10.89% 22.53% 18.16%
5-Year CAGR 8.44% 23.24% 19.79%

* Compound Annual Growth Rate

Here are more details on the GSK Pharma share price and the Cipla share price.

Moving on to shareholding structures...

The promoters of GSK Pharma hold a 75.0% stake in the company. In case of Cipla the stake stands at 33.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GSK Pharma and the shareholding pattern of Cipla.

Finally, a word on dividends...

In the most recent financial year, GSK Pharma paid a dividend of Rs 32.0 per share. This amounted to a Dividend Payout ratio of 89.2%.

Cipla paid Rs 8.5, and its dividend payout ratio stood at 24.2%.

You may visit here to review the dividend history of GSK Pharma, and the dividend history of Cipla.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.